Viewing Study NCT01294735

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2026-01-01 @ 8:50 PM
Study NCT ID: NCT01294735
Status: COMPLETED
Last Update Posted: 2012-08-15
First Post: 2011-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
Sponsor: Merck Sharp & Dohme LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrence of Solid Tumor View
None Glioblastoma Multiforme View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Temozolomide View
None glioblastoma multiforme View
None melanoma View
None advanced neoplasm View